Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
Department of Medical Chemistry, Semmelweis University Medical School, Budapest, Hungary.
Cancer Metastasis Rev. 2020 Dec;39(4):1051-1065. doi: 10.1007/s10555-020-09912-8.
The genetic alterations in cancer cells are tightly linked to signaling pathway dysregulation. Ras is a key molecule that controls several tumorigenesis-related processes, and mutations in RAS genes often lead to unbiased intensification of signaling networks that fuel cancer progression. In this article, we review recent studies that describe mutant Ras-regulated signaling routes and their cross-talk. In addition to the two main Ras-driven signaling pathways, i.e., the RAF/MEK/ERK and PI3K/AKT/mTOR pathways, we have also collected emerging data showing the importance of Ras in other signaling pathways, including the RAC/PAK, RalGDS/Ral, and PKC/PLC signaling pathways. Moreover, microRNA-regulated Ras-associated signaling pathways are also discussed to highlight the importance of Ras regulation in cancer. Finally, emerging data show that the signal alterations in specific cell types, such as cancer stem cells, could promote cancer development. Therefore, we also cover the up-to-date findings related to Ras-regulated signal transduction in cancer stem cells.
癌细胞中的遗传改变与信号通路失调密切相关。Ras 是一种控制多种与肿瘤发生相关过程的关键分子,RAS 基因的突变通常导致信号网络的无偏激活,从而推动癌症的进展。在本文中,我们回顾了最近描述突变 Ras 调节的信号途径及其串扰的研究。除了两条主要的 Ras 驱动的信号通路,即 RAF/MEK/ERK 和 PI3K/AKT/mTOR 通路外,我们还收集了新兴的数据,表明 Ras 在其他信号通路中的重要性,包括 RAC/PAK、RalGDS/Ral 和 PKC/PLC 信号通路。此外,还讨论了 microRNA 调节的 Ras 相关信号通路,以强调 Ras 调节在癌症中的重要性。最后,新出现的数据表明,特定细胞类型(如癌症干细胞)中的信号改变可能会促进癌症的发展。因此,我们还涵盖了与癌症干细胞中 Ras 调节的信号转导相关的最新发现。